21 May 2013
Keywords: synosia, announces, 2nd, cns, deal, roche, switzerland
Article | 16 March 2009
Switzerland's Synosia Therapeutics has entered into a second central nervous system disorder agreement with drug major Roche, adding a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2009
20 May 2013
© 2013 thepharmaletter.com